Fundamental study of memory impairment and non-cognitive behavioral alterations in APPswe/PS1dE9 mice

Yakugaku zasshi : Journal of the Pharmaceutical Society of Japan
Nobuhiko TaniuchiHachiro Sugimoto

Abstract

In addition to cognitive decline, Alzheimer's disease patients also exhibit non-cognitive symptoms commonly referred to as behavioral and psychological symptoms of dementia, or BPSD. These symptoms have a serious impact on the quality of life of these patients, as well as that of their caregivers, but there are currently no effective therapies. The amyloid β-peptide (Aβ) is suspected to play a central role in the cascade leading to Alzheimer's disease, but the precise mechanisms are still incompletely known. To assess the influence of Aβ pathology on cognitive and non-cognitive behaviors, we examined locomotor activity, motor coordination, and spatial memory in male and female APPswePS1dE9 mice (Alzheimer's disease model, double transgenic mice expressing an amyloid precursor protein with Swedish mutation and a presenilin-1 with deletion of exon 9) at 5 months of age, when the mice had subtle Aβ deposits, and again at 9 months of age, when the mice had numerous Aβ deposits. Compared to wild-type mice, the male and female APPswe/PS1dE9 mice showed normal motor coordination in the rotarod test at both 5 and 9 months. In the Morris water maze test, male and female APPswe/PS1dE9 mice showed impaired spatial memory at 9 months; howe...Continue Reading

References

Aug 15, 1991·Proceedings of the National Academy of Sciences of the United States of America·N W KowallB A Yankner
Aug 14, 1991·European Journal of Pharmacology·C J PikeC W Cotman
Mar 29, 2001·Physiological Reviews·D J Selkoe
May 29, 2002·Proceedings of the National Academy of Sciences of the United States of America·Joo-Yong LeeJae-Young Koh
Mar 18, 2004·Clinics in Geriatric Medicine·Sanford I Finkel
Apr 2, 2004·The Journal of Neuroscience : the Official Journal of the Society for Neuroscience·Zhiming SuoBarry W Festoff
Nov 22, 2005·Mechanisms of Ageing and Development·Alessia LanariLucilla Parnetti
Jan 13, 2006·Proceedings of the National Academy of Sciences of the United States of America·Magdalena SastreMichael T Heneka
Feb 3, 2006·The Journal of Neuroscience : the Official Journal of the Society for Neuroscience·Michael T HenekaMatthias Staufenbiel
Jul 25, 2006·Behavioural Brain Research·Hannelore GoddynRudi D'Hooge
Oct 24, 2006·Neuroscience and Biobehavioral Reviews·L Giménez-LlortA Fernández-Teruel
Jun 8, 2007·The Journal of Neuroscience : the Official Journal of the Society for Neuroscience·William E KlunkSteven T DeKosky
Dec 20, 2007·Neuroreport·Nobuhiko TaniuchiHachiro Sugimoto
Jun 3, 2008·Nature Medicine·Terrence TownRichard A Flavell
Oct 29, 2008·Brain Research Bulletin·Longxuan LiWilliam Z Suo
Nov 13, 2008·Archives of Neurology·Howard Jay AizensteinWilliam E Klunk
May 13, 2014·Alzheimer's & Dementia : the Journal of the Alzheimer's Association
Aug 15, 2014·Clinical and Experimental Pharmacology & Physiology·Stephen R EdwardsMaree T Smith

❮ Previous
Next ❯

Citations


❮ Previous
Next ❯

Related Concepts

Related Feeds

Alzheimer's Disease: Animal Models

Alzheimer's disease is a neurodegenerative disease which can be studied using various experimental systems. This feed focuses on animal models used for Alzheimer's disease research.

Alzheimer's Disease: Amyloid Beta

Alzheimer's disease is a neurodegenerative disease associated with the accumulation of amyloid plaques in the brain; these plaques are comprised of amyloid beta deposits. Here is the latest research in this field.

Alzheimer's Disease: APP

Amyloid precursor protein (APP) proteolysis is critical for the development of Alzheimer's disease, a neurodegenerative disease associated with accumulation of amyloid plaques in the brain. Here is the latest research on APP and Alzheimer's disease.